Stage FocusSeed, Series A
GeographySoutheast Asia
TypeGovernment
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeGovernment Fund
ExposureMostly DeepTech Investments
Bio
ClavystBio was established in 2021 by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek — Singapore's sovereign wealth fund. Since 2022, the firm has committed over $220M to biotech, diagnostics, and digital health companies, with 23 total investments including 11 direct companies and 3 early-stage VC fund positions.
Focus areas include cell and gene therapy, biomarkers, digital heal...
Notable Investments
N
NSG BioLabsSimilar Funds
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
AV
Astellas Venture Management
South San Francisco, United States
Industrial / CVCBiotechMedtechSeedSeries A